Skip to main content

ADVERTISEMENT

Erin McGuinness

News
11/29/2021
The COVID-19 pandemic has had a negative emotional and physical impact on patients with multiple sclerosis (MS), according to new research, the findings of which were presented in a poster at the Consortium of Multiple Sclerosis Centers 2021...
The COVID-19 pandemic has had a negative emotional and physical impact on patients with multiple sclerosis (MS), according to new research, the findings of which were presented in a poster at the Consortium of Multiple Sclerosis Centers 2021...
The COVID-19 pandemic has had a...
11/29/2021
Neurology
News
01/27/2022
According to recent findings published in JAMA Neurology, erenumab can be safe and effective for the treatment of migraine for patients with or without history of aura.
According to recent findings published in JAMA Neurology, erenumab can be safe and effective for the treatment of migraine for patients with or without history of aura.
According to recent findings...
01/27/2022
Neurology
News
10/14/2021
Levosimendan was not better than placebo at maintaining respiratory function for patients with amyotrophic lateral sclerosis, according to a recent study published in The Lancet Neurology.
Levosimendan was not better than placebo at maintaining respiratory function for patients with amyotrophic lateral sclerosis, according to a recent study published in The Lancet Neurology.
Levosimendan was not better than...
10/14/2021
Neurology
10/07/2021
Long-term anticholinergic medication exposure can cause long-term consequences that surpass previously documented short-term cognitive effects, according to a review recently published in the Journal of Neurochemistry.
Long-term anticholinergic medication exposure can cause long-term consequences that surpass previously documented short-term cognitive effects, according to a review recently published in the Journal of Neurochemistry.
Long-term anticholinergic...
10/07/2021
Psych Congress Network
News
09/14/2021
New findings show an increase in suicide-related emergency department encounters in some months during the COVID-19 pandemic when compared with rates in 2019, according to results from a cross-sectional study.
New findings show an increase in suicide-related emergency department encounters in some months during the COVID-19 pandemic when compared with rates in 2019, according to results from a cross-sectional study.
New findings show an increase in...
09/14/2021
Psych Congress Network
News
11/29/2021
Experts have used rapid prototyping and human factors studies (HFS) to develop Floodlight MS, an application that can be used for remote functional assessment of multiple sclerosis (MS). These details were presented in a poster presented at...
Experts have used rapid prototyping and human factors studies (HFS) to develop Floodlight MS, an application that can be used for remote functional assessment of multiple sclerosis (MS). These details were presented in a poster presented at...
Experts have used rapid...
11/29/2021
Neurology
Conference Coverage
02/09/2022
Management of unruptured arteriovenous malformations (AVMs) has changed since the publishing of the ARUBA trial findings, according to data presented at ISC 2022.
Management of unruptured arteriovenous malformations (AVMs) has changed since the publishing of the ARUBA trial findings, according to data presented at ISC 2022.
Management of unruptured...
02/09/2022
Neurology
News
09/07/2021
A recent meta-analysis mapping rates of young-onset dementia found that 119 per 100 000 patients between the ages of 30 and 64 are affected.
A recent meta-analysis mapping rates of young-onset dementia found that 119 per 100 000 patients between the ages of 30 and 64 are affected.
A recent meta-analysis mapping...
09/07/2021
Psych Congress Network
News
09/27/2021
Patients with multiple sclerosis (MS) treated with ocrelizumab can develop vaccine-specific T-cell responses to the SARS-CoV-2 messenger RNA vaccine, despite ocrelizumab being a B-cell-depleting agent, according to new research published in...
Patients with multiple sclerosis (MS) treated with ocrelizumab can develop vaccine-specific T-cell responses to the SARS-CoV-2 messenger RNA vaccine, despite ocrelizumab being a B-cell-depleting agent, according to new research published in...
Patients with multiple sclerosis...
09/27/2021
Neurology
News
10/05/2021
Dietary interventions to adjust fatty acid intake combined with usual care can help improve variability of mood related symptoms for patients with bipolar disorders (BD), according to new research from the Penn State College of Medicine...
Dietary interventions to adjust fatty acid intake combined with usual care can help improve variability of mood related symptoms for patients with bipolar disorders (BD), according to new research from the Penn State College of Medicine...
Dietary interventions to adjust...
10/05/2021
Psych Congress Network